SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007641
Filing Date
2024-05-09
Accepted
2024-05-09 16:51:52
Documents
88
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20240331x10q.htm   iXBRL 10-Q 2316518
2 EX-10.2 chrs-20240331xex10d2.htm EX-10.2 29656
3 EX-31.1 chrs-20240331xex31d1.htm EX-31.1 14068
4 EX-31.2 chrs-20240331xex31d2.htm EX-31.2 14969
5 EX-32.1 chrs-20240331xex32d1.htm EX-32.1 12069
  Complete submission text file 0001558370-24-007641.txt   10184979

Data Files

Seq Description Document Type Size
6 EX-101.SCH chrs-20240331.xsd EX-101.SCH 78308
7 EX-101.CAL chrs-20240331_cal.xml EX-101.CAL 83141
8 EX-101.DEF chrs-20240331_def.xml EX-101.DEF 353326
9 EX-101.LAB chrs-20240331_lab.xml EX-101.LAB 616983
10 EX-101.PRE chrs-20240331_pre.xml EX-101.PRE 512645
92 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240331x10q_htm.xml XML 1709185
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 24931568
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)